APA (7th ed.) Citation

DA, F., Y, I., FD, J., G, d. R., D, L., R, S., . . . WW, L. (2022). MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression. NPJ precision oncology, 6(1), 88. https://doi.org/10.1038/s41698-022-00328-x

Chicago Style (17th ed.) Citation

DA, Farnsworth, et al. "MEK Inhibitor Resistance in Lung Adenocarcinoma Is Associated with Addiction to Sustained ERK Suppression." NPJ Precision Oncology 6, no. 1 (2022): 88. https://doi.org/10.1038/s41698-022-00328-x.

MLA (9th ed.) Citation

DA, Farnsworth, et al. "MEK Inhibitor Resistance in Lung Adenocarcinoma Is Associated with Addiction to Sustained ERK Suppression." NPJ Precision Oncology, vol. 6, no. 1, 2022, p. 88, https://doi.org/10.1038/s41698-022-00328-x.